Adrenergic and cholinergic drugs as episode and vulnerability markers of affective disorders and schizophrenia.
D000342:Affective Symptoms / Q000175:diagnosis*; D006801:Humans; D010277:Parasympathomimetics; D012559:Schizophrenia / Q000175:diagnosis*; D013566:Sympathomimetics
D010277:Parasympathomimetics; D013566:Sympathomimetics